| scholarly article | Q13442814 |
| P2093 | author name string | Sara S Strom | |
| Carol J Etzel | |||
| Randa El-Zein | |||
| Yun Xing | |||
| Claudia M Monroy | |||
| Andrea C Cortes | |||
| Amanda L Collier | |||
| P2860 | cites work | Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein | Q24561768 |
| Solution structure of the single-strand break repair protein XRCC1 N-terminal domain | Q27619500 | ||
| BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III | Q28188887 | ||
| Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans | Q28263439 | ||
| A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility | Q28295511 | ||
| Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer | Q31160913 | ||
| Polymorphisms of the DNA repair gene XRCC1 and the frequency of somatic mutations at the glycophorin A locus in newborns | Q33183668 | ||
| Evaluating HapMap SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genes | Q33228354 | ||
| Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death | Q33229735 | ||
| Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. | Q33285918 | ||
| XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency | Q77861457 | ||
| Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin's lymphoma | Q79300657 | ||
| A risk model for prediction of lung cancer | Q80242314 | ||
| Lack of association of XRCC1 codon 399Gln polymorphism with chronic myelogenous leukemia | Q80789422 | ||
| Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain | Q33294473 | ||
| Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity | Q33863075 | ||
| Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review | Q33936434 | ||
| Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer | Q33951229 | ||
| DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. | Q34154136 | ||
| Familial clustering of breast cancer: Possible interaction between dna repair proficiency and radiation exposure in the development of breast cancer | Q34304456 | ||
| How nucleotide excision repair protects against cancer | Q34568150 | ||
| Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer | Q35165838 | ||
| Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions | Q35221734 | ||
| Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes | Q35849056 | ||
| Use of biomarkers to characterize functions of polymorphic DNA repair genotypes | Q35911645 | ||
| XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review | Q36481400 | ||
| Pharmacogenetics of cancer chemotherapy | Q36671536 | ||
| Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma | Q38326635 | ||
| DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample | Q39583788 | ||
| Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair | Q39674379 | ||
| XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro | Q39718210 | ||
| Variability in DNA repair and individual susceptibility to genotoxins. | Q40381876 | ||
| Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. | Q40458175 | ||
| Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma | Q40825244 | ||
| Genetic susceptibility to cancer | Q40826940 | ||
| Reduced DNA repair capacity in lung cancer patients | Q41167956 | ||
| XRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin disease | Q42467540 | ||
| Polymorphisms in the DNA repair gene XRCC1 associated with basal cell carcinoma and squamous cell carcinoma of the skin in a Korean population | Q42509532 | ||
| Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma | Q44500715 | ||
| Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma | Q44594921 | ||
| Polymorphisms in DNA repair and metabolic genes in bladder cancer | Q44701256 | ||
| Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer | Q45144140 | ||
| DNA repair gene polymorphisms and probability of p53 mutation in bladder cancer | Q46572749 | ||
| Polymorphisms of DNA repair gene XRCC3 Thr241Met and risk of gastric cancer in a Chinese population | Q47956912 | ||
| Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer | Q50934448 | ||
| Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. | Q51017194 | ||
| Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer | Q53365544 | ||
| XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects | Q53396019 | ||
| Association of gene polymorphisms in the DNA repair gene XPD with risk of non-Hodgkin's lymphoma | Q53494860 | ||
| Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer | Q53653112 | ||
| Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut | Q56994843 | ||
| Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer | Q57568638 | ||
| Genetic Variation in Base Excision Repair Genes and the Prevalence of Advanced Colorectal Adenoma | Q57780598 | ||
| Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma | Q57833833 | ||
| Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia | Q58419125 | ||
| Influence of DNA repair polymorphisms on biomarkers of genotoxic damage in peripheral lymphocytes of healthy subjects. | Q64900772 | ||
| X-ray-induced chromatid damage in relation to DNA repair and cancer incidence in family members | Q70768827 | ||
| Evolution of Hodgkin's disease | Q71739027 | ||
| An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study | Q73773463 | ||
| The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK | Q74272524 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 1651-1659 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk | |
| P478 | volume | 115 |
| Q47100172 | A Polymorphism Located Near PMAIP1/Noxa Gene Influences Susceptibility to Hodgkin Lymphoma Development in South India |
| Q37857869 | Abnormalities of DNA repair mechanisms in common hematological malignancies |
| Q28386513 | Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis. |
| Q28385328 | Association between the XPG Asp1104His and XPF Arg415Gln polymorphisms and risk of cancer: a meta-analysis |
| Q46927892 | Association between the XRCC3 T241M polymorphism and risk of cancer: Evidence from 157 case–control studies |
| Q39241141 | Association of Human Cytomegalovirus with Hodgkin’s Disease and Non-Hodgkin’s lymphomas |
| Q53260519 | Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph). |
| Q50587999 | Associations of DNA-repair gene polymorphisms with a genetic susceptibility to ionizing radiation in residents of areas with high radon (222Rn) concentration |
| Q91757149 | CD163 is a predictive biomarker for prognosis of classical Hodgkin's lymphoma in Saudi patients |
| Q30252147 | Candidate gene association studies and risk of Hodgkin lymphoma: a systematic review and meta-analysis. |
| Q50970324 | De novo acute myeloid leukemia risk factors: a Texas case-control study |
| Q35091367 | Hodgkin lymphoma risk: Role of genetic polymorphisms and gene–gene interactions in DNA repair pathways |
| Q40969169 | Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population |
| Q33735802 | Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia |
| Q34557179 | Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies |
| Q92237158 | Urinary 8-hydroxydeoxyguanosine in relation to XRCC1 rs25487 G/A (Arg399Gln) and OGG1 rs1052133 C/G (Ser326Cys) DNA repair genes polymorphisms in patients with chronic hepatitis C and related hepatocellular carcinoma |
| Q36253844 | Using haplotype analysis to elucidate significant associations between genes and Hodgkin lymphoma |
| Q37473063 | XPC promotes MDM2-mediated degradation of the p53 tumor suppressor |
| Q55101935 | XPG rs17655 G>C polymorphism associated with cancer risk: evidence from 60 studies. |
| Q51004249 | XRCC1Arg194Trp and Arg399Gln polymorphisms are significantly associated with shorter survival in acute myeloid leukemia |
Search more.